Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Dishman Carbogen Amcis Limited
DCAL | NSE
169.01
INR-5.54
-3.17%
DCAL | NSE
Loading StockChartView...
About Dishman Carbogen Amcis Limited
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/03/2024
As of date
24/04/2026
Close
169.01
Open
176.79
High
176.79
Low
167.00
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs active pharmaceutical ingredients phase transfer catalysts quaternary ammonium compounds phosphoranes wittig reagents vitamin D products fine chemicals hand and body wash sanitizers antiseptics vitamin D analogues cholesterol lanolin-related products disinfectant formulations and various pharmaceutical and cosmetic-related products as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad India. As of March 30 2022 Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.
View LessDCAL | NSE
Risk
77.8
Sharpe
-0.44
Luna's Score
40/100
Recommendation
Sell
Luna says (DCAL | NSE)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
34.3%1 month
77.8%3 months
67.3%6 months
61.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.54
Debt to equity
0.41
Debt to assets
0.24
Ent. to EBITDA
16.38
Ent. to rev.
1.94
PEG
-
Other Fundamentals
EBITDA
2.27B
MarketCap
26.50B
MarketCap(USD)
275.66M
Div. yield
-
Op. margin
-7.95
Erngs. growth
315.40
Rev. growth
-27.60
Ret. on equity
-2.68
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
27.54
Range1M
51.25
Range3M
105.35
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.53
Price X volume
42.64M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 16.38 | 54.00 | Cheaper |
| Ent. to Revenue | 1.94 | 7.68 | Cheaper |
| PE Ratio | - | 53.67 | - |
| Price to Book | 0.54 | 6.76 | Cheaper |
| Dividend Yield | - | 0.26 | - |
| Std. Deviation (3M) | 67.26 | 50.01 | Riskier |
| Debt to Equity | 0.41 | -0.16 | Expensive |
| Debt to Assets | 0.24 | 0.17 | Expensive |
| Market Cap | 26.50B | 129.43B | Emerging |
